These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 1834112

  • 1. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction.
    De Rossi A, Mammano F, Del Mistro A, Chieco-Bianchi L.
    Eur J Cancer; 1991; 27(7):835-8. PubMed ID: 1834112
    [Abstract] [Full Text] [Related]

  • 2. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.
    Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS.
    Science; 1989 Apr 28; 244(4903):471-5. PubMed ID: 2655084
    [Abstract] [Full Text] [Related]

  • 3. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods.
    Colombo E, Magistrelli C, Mendozzi E, Cattaneo E, Achilli G, Ferrante P.
    J Med Virol; 1995 Sep 28; 47(1):10-5. PubMed ID: 8551251
    [Abstract] [Full Text] [Related]

  • 4. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB.
    Am J Trop Med Hyg; 1997 Aug 28; 57(2):142-8. PubMed ID: 9288805
    [Abstract] [Full Text] [Related]

  • 5. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
    Wattel E, Mariotti M, Agis F, Gordien E, Prou O, Courouce AM, Rouger P, Wain-Hobson S, Chen IS, Lefrère JJ.
    J Infect Dis; 1992 Feb 28; 165(2):369-72. PubMed ID: 1730903
    [Abstract] [Full Text] [Related]

  • 6. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM, Remesar M, del Pozo A, Sen L.
    J Med Virol; 2004 Oct 28; 74(2):323-7. PubMed ID: 15332282
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J, Robert-Guroff M, Blattner WA, Pipkorn R.
    J Acquir Immune Defic Syndr (1988); 1992 Oct 28; 5(3):294-302. PubMed ID: 1371319
    [Abstract] [Full Text] [Related]

  • 9. Serologic differentiation of human T lymphotropic virus type I from type II infection by synthetic peptide immunoassays.
    Roberts CR, Mitra R, Hyams K, Brodine SK, Lal RB.
    J Med Virol; 1992 Apr 28; 36(4):298-302. PubMed ID: 1578221
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH, McAlpine L, Mortimer PP.
    J Med Virol; 1993 May 28; 40(1):83-5. PubMed ID: 8099946
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil.
    Farias de Carvalho SM, Pombo de Oliveira MS, Thuler LC, Rios M, Coelho RC, Rubim LC, Silva EM, Reis AM, Catovsky D.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul 01; 15(3):238-42. PubMed ID: 9257659
    [Abstract] [Full Text] [Related]

  • 16. Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.
    Olaleye OD, Ekweozor CC, Li ZL, Opala IE, Sheng Z, Onyemenem TN, Rasheed S.
    Arch Virol; 1996 Jul 01; 141(2):345-55. PubMed ID: 8634025
    [Abstract] [Full Text] [Related]

  • 17. No evidence for human T-cell leukemia virus type I or human T-cell leukemia virus type II infection in patients with multiple sclerosis.
    Perl A, Nagy K, Pazmany T, Isaacs C, Baraczka K, Szabo T, Feher J.
    Arch Neurol; 1990 Oct 01; 47(10):1061-3. PubMed ID: 2222235
    [Abstract] [Full Text] [Related]

  • 18. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J, Baillou A, Barin F, Verdier M, Janvier B, Denis F.
    J Clin Microbiol; 1993 Jun 01; 31(6):1481-5. PubMed ID: 8314990
    [Abstract] [Full Text] [Related]

  • 19. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
    Lipka JJ, Santiago P, Chan L, Reyes GR, Samuel KP, Blattner WA, Shaw GM, Hanson CV, Sninsky JJ, Foung SK.
    J Infect Dis; 1991 Aug 01; 164(2):400-3. PubMed ID: 1856487
    [Abstract] [Full Text] [Related]

  • 20. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.
    Heneine W, Khabbaz RF, Lal RB, Kaplan JE.
    J Clin Microbiol; 1992 Jun 01; 30(6):1605-7. PubMed ID: 1624585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.